Overall cohort (n = 65) | Number, % |
---|---|
Male sex | 41 (63) |
Median age (years) | 8.7 (IQR 3–15 years; range 3 months–18 years) |
Patient age | Â |
 < 6 months old | 3 (5) |
 6 months–4 years old | 20 (31) |
 5 years old–11 years old | 16 (24) |
 ≥ 12 years old | 26 (40) |
Pre-existing comorbidities | Â |
 Pulmonary | 20 (31) |
 Cardiac | 4 (6) |
 Hematologic/oncologic | 20 (31) |
 Neurologic | 13 (20) |
 Chromosomal abnormality | 7 (11) |
 Obesity | 13 (20) |
Patients with ≥ 3 comorbidities | 23 (35) |
Mild-moderate COVID-19, high-risk for severe disease (n = 22) | Â |
Male sex | 14 (64) |
Median age (years) | 8.5 (IQR years 4.5–14.5 years; range 1–17 years) |
Patient age | Â |
 < 6 months old | 0 (0) |
 6 months–4 years old | 6 (27) |
 5 years old–11 years old | 9 (41) |
 ≥ 12 years old | 7 (32) |
Risk factor for severe disease | Â |
 Malignancy | 13 (59) |
 Hematologic disorder, non-malignant) | 5 (23) |
 Neurologic | 2 (9) |
 Other immunocompromised state | 2 (9) |